Selenium antagonism of cadmium-induced inhibition of hepatic drug metabolism in the male rat

1981 ◽  
Vol 58 (1) ◽  
pp. 57-66 ◽  
Author(s):  
Johnnie L. Early ◽  
R.Craig Schnell
1984 ◽  
Vol 107 (4) ◽  
pp. 506-512 ◽  
Author(s):  
Paul Skett ◽  
Rosemary A. Cochrane ◽  
Lesley A. Joels

Abstract. Diabetes mellitus exerts a sex-dependent effect on hepatic drug metabolism in the rat and it has been suggested that this is due to a reduction in serum androgen levels. This study shows that the effect of diabetes is only seen in the presence of androgen and that testosterone can reverse the effect of diabetes on drug metabolism. Diabetes, however, does not consistently cause a reduction in serum testosterone. Diabetes and androgens, therefore, are postulated to interact in their effects on drug metabolism by action on a common mediator. It is suggested that this mediator is growth hormone, which is known to be affected by the androgens and insulin and to be involved in sex differences in drug metabolism in the rat.


1969 ◽  
Vol 18 (9) ◽  
pp. 2288-2292 ◽  
Author(s):  
A.E. Wade ◽  
F.E. Greene ◽  
R.H. Ciordia ◽  
J.S. Meadows ◽  
W.O. Caster

1986 ◽  
Vol 112 (2) ◽  
pp. 300-304 ◽  
Author(s):  
Marion MacFarlane ◽  
Paul Skett

Abstract. Streptozotocin (STZ) causes a rise in serum glucose, triglycerides and ketones and a fall in insulin and also leads to changes in drug metabolism. Results from rats left for 20 days indicate that there is no correlation between the effects of STZ on hepatic and serum parameters. The present study investigated the time course of the effect of STZ on hepatic drug metabolism, protein and cytochrome P-450 content and serum glucose and triglyceride concentration. STZ caused the induction of diabetes by 2 h which disappeared at 8 h and reappeared at 24 h. Drug metabolism was reduced after 1 h, returned to control levels at 2 h and remained there until 24 h. Liver protein was increased at 1 and 72 h but cytochrome P-450 was unaffected. The initial increase in serum parameters was not accompanied by changes in hepatic parameters and, thus, the two effects of streptozotocin may not be related.


2020 ◽  
Vol 88 (4) ◽  
pp. 45
Author(s):  
Silviya Abarova ◽  
Lyubka Tancheva ◽  
Rumen Nikolov ◽  
Julia Serkedjieva ◽  
Elitsa Pavlova ◽  
...  

The decreased hepatic drug metabolism (predominately first phase) is one of the essential reasons for numerous side effects and for increased drug toxicity during influenza virus infection (IVI). The present study aims to investigate some mechanisms of the preventive effect of a standardized polyphenol complex from the medicinal plant Geranium sanguineum L. (PPhC) (10 mg/kg nasally). A verified experimental model of IVI A/Aichi/2/68 (H3N2) (4.5 lg LD50) in male ICR (Institute of Cancer Research, USA) mice was used. Changes in hepatic monooxygenase activities as well as nicotinamide adenine dinucleotide phosphate (NADPH)-cytochrome C reductase activity and cytochtome P450 content were studied on days 2, 6, 9, 21 of the infection together with thiobarbituric acid reactive substances in the liver supernatant. Our data clearly demonstrates that IVI affects all components of the electronic chain of cytochrome P-450. N-demethylases and hydroxylases as well as the activity of cytochrome C reductase and cytochtome P-450 content were decreased in the course of the virus infection. This implies that free radicals play an important role not only in the pathogenesis of IVI, but also in the modulation of the hepatic monooxygenase activity. This is also consistent with the established polyphenol complex PPhC from the medicinal plant Geranium sanguineum L. preventive effect against increased thiobarbituric acid reactive substances (TBARS)-levels. PPhC restored most of the monooxygenase activities that were inhibited in IVI animals, even over the control levels, probably via multiple mechanisms that may entail antioxidant activity and selective antiviral and protein-binding effects. In contrast to infected animals, in healthy mice, PPhC showed moderate reversible inhibitory effect on hepatic monooxygenase activities.


2001 ◽  
Vol 71 (11) ◽  
pp. 1585-1592 ◽  
Author(s):  
Shuang Bai ◽  
Lane J. Brunner ◽  
Stanislaw M. Stepkowski ◽  
Kimberly L. Napoli ◽  
Barry D. Kahan

JAMA ◽  
1976 ◽  
Vol 236 (14) ◽  
pp. 1612
Author(s):  
Nicholas F. LaRusso

1963 ◽  
Vol 12 (4) ◽  
pp. 341-348 ◽  
Author(s):  
Larry A. Rogers ◽  
Robert L. Dixon ◽  
James R. Fouts

Sign in / Sign up

Export Citation Format

Share Document